Anjali S. Advani, MD1, Anna B Moseley, MS2,3*, Kristen M. O'Dwyer, MD4, Brent L. Wood, MD, PhD5, Jae H. Park, MD6, Matthew J. Wieduwilt, MD7*, Deepa Jeyakumar, MD8, George Yaghmour, MD9, Ehab L. Atallah, MD10, Aaron T. Gerds, MD, MS11, Susan M. O'Brien12, Jane L. Liesveld, MD13, Megan Othus, PhD3,14, Mark R. Litzow, MD15, Richard M Stone, MD16, Elad Sharon, MD, MPH17*, Cecilia C.S. Yeung, MD2, Jerald P. Radich, MD18 and Harry P. Erba, MD, PhD19
1Leukemia Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
2Fred Hutchinson Cancer Center, Seattle, WA
3SWOG Statistics and Data Mangement Center, Seattle, WA
4University of Rochester, Rochester, NY
5Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA
6Memorial Sloan Kettering Cancer Center, New York, NY
7Atrium Health Wake Forest Baptist, Winston Salem, NC
8Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California Irvine, Orange, CA
9USC Norris Comprehensive Cancer Center, Los Angeles, CA
10Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
11Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
12Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, CA
13James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY
14Public Health Science Division, Fred Hutchinson Cancer Center, Seattle, WA
15Division of Hematology, Mayo Clinic, Rochester, MN
16Dana-Farber Cancer Institute, Boston, MA
17NCI Cancer Therapy Evaluation program (CTEP), Bethesda, MD
18Translational Sciences & Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA
19Duke Cancer Institute, Durham, NC